MetLife Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

MetLife Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-21,165	Closed	-$2.89M	–	2340
2020 Q3	$2.89M	Sell	21,165 -677	-3%	-$72K	0.03%	555
2020 Q2	$2.11M	Buy	21,842 +3,074	+16%	+$256K	0.02%	695
2020 Q1	$880K	Sell	18,768 -1,309	-7%	-$83.9K	0.01%	962
2019 Q4	$1.46M	Hold	20,077	–	–	0.02%	933
2019 Q3	$1.05M	Hold	20,077	–	–	0.01%	1042
2019 Q2	$1.01M	Buy	20,077 +4,925	+33%	+$240K	0.01%	1099
2019 Q1	$788K	Hold	15,152	–	–	0.01%	1191
2018 Q4	$740K	Hold	15,152	–	–	0.01%	1150
2018 Q3	$988K	Buy	15,152 +921	+6%	+$54.2K	0.01%	1127
2018 Q2	$707K	Buy	14,231 +5,109	+56%	+$247K	0.01%	1197
2018 Q1	$445K	Hold	9,122	–	–	0.01%	1437
2017 Q4	$384K	Buy	+9,122	New	+$352K	﹤0.01%	1560

MetLife Investment Management's MYOK Position: Q4 2020 in Review

MetLife Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 21,165 shares — an estimated $2.89M sold.

MetLife Investment Management first reported a position in MYOK in Q4 2017 and held it in 12 quarters. The position peaked at $2.89M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

MetLife Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
MetLife Investment Management sold 21,165 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.89M.
MetLife Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 12 quarters.
MetLife Investment Management's MyoKardia, Inc. Common Stock position peaked at $2.89M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.